For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.
Study of Brain Network Activation Technology in Treating Depression
This is a study to evaluate whether brain network activation technology can predict the effects of treatment for depression with an FDA-approved antidepressant.
Recent studies have shown that brain network activation analysis (BNA) may be used as a tool to improve diagnosis and monitor treatment response in major depressive disorder. BNA is a method of analyzing brain activity using a series of EEG (electroencephalogram) recording sessions. During the EEG, your brain waves are recorded as you perform a series of tasks on a computer screen. The EEG procedure will last approximately 1½ to 2 hours and is performed 4 times during the study.
In order to participate you must meet the following criteria:
- Are 18 to 65 years of age.
- Have been diagnosed with depression.
- Are right-handed.
You will be excluded from the study if any of the following criteria apply to you:
- Have a primary psychiatric disorder other than depression.
- Have a condition that may interfere with the EEG recording (such as a hair or scalp condition, severe head injury, Alzheimer’s or Parkinson’s disease, etc.).
- Are pregnant or breastfeeding, or have an unstable medical condition.
This is a partial list of inclusion and exclusion criteria.